You have all been sucked in very successfully into the other thread by a certain poster, read Hunterr’s post; it’s right on the money and this is exactly what Mason attempted previously on the other company’s threads.
I can only say to take the CEO’s advice and DYOR and invest accordingly, there’s plenty of wriggle room in the oncology space for multiple success stories.
Add to My Watchlist
What is My Watchlist?
